APA (7th ed.) Citation

Noureddini, M., Mobasseri, N., Karimian, M., Behjati, M., & Nikzad, H. (2018). Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis. The journal of gene medicine, 20(10-11), e3053-n/a. https://doi.org/10.1002/jgm.3053

Chicago Style (17th ed.) Citation

Noureddini, Mahdi, Narges Mobasseri, Mohammad Karimian, Mohaddeseh Behjati, and Hossein Nikzad. "Arg399Gln Substitution in XRCC1 as a Prognostic and Predictive Biomarker for Prostate Cancer: Evidence from 8662 Subjects and a Structural Analysis." The Journal of Gene Medicine 20, no. 10-11 (2018): e3053-n/a. https://doi.org/10.1002/jgm.3053.

MLA (9th ed.) Citation

Noureddini, Mahdi, et al. "Arg399Gln Substitution in XRCC1 as a Prognostic and Predictive Biomarker for Prostate Cancer: Evidence from 8662 Subjects and a Structural Analysis." The Journal of Gene Medicine, vol. 20, no. 10-11, 2018, pp. e3053-n/a, https://doi.org/10.1002/jgm.3053.